IP Library Granted Patent US 8,703,449
Granted Patent B2
US 8,703,449 · App. 13/250,492 · Granted Apr 22, 2014

Bioabsorbable polymer containing 2-hydroxyacid monomers

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,703,449
App. No.
13/250,492
Granted
Apr 22, 2014
Kind
B2
Abstract

Genetically engineered organisms for production of PHA copolymers containing 2-hydroxyacid monomers and the methods of making and using thereof have been developed. The copolymers containing 2-hydroxyacid monomers can be synthesized via biosynthesis by the action of a PHA polymerase in a living cell. By changing the genetic background of the cells, one can control specific metabolic pathways allowing control of the level of glycolic acid co-monomer in the PHA polymer.

Claims (13)

1. A method of producing a glycolic acid-containing polyhydroxyalkanoate polymer comprising

Providing a feedstock comprising glycolic acid, 1,4-butane dial, 4-hydroxybutyric acid, or combinations thereof to bacteria expressing a polyhydroxyalkanoate (PHA) synthase and at least one enzyme selected from the group consisting of acetoacetyl-CoA reductases and beta-ketoacyl-CoA thiolases and at least one enzyme for the production of glycolyl-CoA selected from the group consisting of aldehyde dehydrogenase, diol oxidoreductase, enoyl-CoA dehydrase, beta acyl-CoA dehydrogenase, thiolases, and acyl-CoA transferase,

to produce the glycolic acid-containing polyhydroxyalkanoate polymer.

2. The method of claim 1 wherein the PHA synthase is a synthase of poly(3-hydroxyalkanoate) or poly(4-hydroxyalkanaote).

3. The method of claim 1 wherein the PHA synthase is poly(3-hydroxyalkanoate) synthase.

4. The method of claim 1 wherein the PHA synthase is poly(4-hydroxyalkanoate) synthase.

5. The method of claim 4 wherein the PHA synthase is poly(4-hydroxybutyrate) synthase.

6. The method of claim 1 wherein the bacteria is E. coli.

7. The method of claim 1 wherein the bacteria is E. coli having mutations selected from fadR601 and atoC constitutive mutations.

8. The method of claim 1 wherein the aldehyde dehydrogenase is from E. coli , wherein the diol oxidoreductase is from Klebsiella pneumoniae , and wherein the acyl-CoA transferase is from Clostridium kluyveri.

9. The method of claim 1 comprising feeding 1,4-butanediol and glucose to the bacteria.

10. The method of claim 1 comprising feeding glycolic acid to the bacteria.

11. The method of claim 1 comprising feeding 4-hydroxybutyric acid to the bacteria.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Oct 5, 2023
From: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
To: TEPHA, INC.
Reel/Frame 065156/0223 →
SECURITY INTEREST Recorded Oct 23, 2020
From: TEPHA, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT
Reel/Frame 054224/0693 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 19, 2017
From: CJ RESEARCH CENTER LLC
To: CJ CHEILJEDANG CORPORATION
Reel/Frame 042522/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 3, 2017
From: METABOLIX, INC.
To: CJ RESEARCH CENTER LLC
Reel/Frame 041234/0890 →
ADDRESS CHANGE Recorded May 2, 2016
From: METABOLIX, INC.
To: METABOLIX, INC.
Reel/Frame 038665/0359 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2011
From: MARTIN, DAVID P.; SKRALY, FRANK A.
To: METABOLIX, INC.; TEPHA, INC.
Reel/Frame 027004/0609 →